Company intelligence / Profile preview

Laplace Interventional

Minneapolis/Plymouth, Minnesota, United Stateslaplaceint.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Laplace Interventional’s TTVR device has been implanted in at least 22 patients in the US and 25 globally as part of its Early Feasibility Study. Initial results are encouraging, with patients discharged within 1–2 days post-procedure and doing well. The device is not yet approved by regulatory authorities and remains investigational.

Therapeutic areas: Cardiovascular
Modalities: DeviceProsthetic valve
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Laplace Interventional.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laplace Interventional.

Explore the full profile